Radiotherapeutic agents: Properties, dosimetry, and radiobiologic considerations

Dougherty, 1948, Heavy and radioactive isotopes in clinical and experimental medicine, vol 1, 1 Lawrence, 1940, Nuclear physics and therapy: preliminary report on a new method for the treatment of leukemia and polycythemia, Radiology, 35, 51, 10.1148/35.1.51 Hertz, 1942, Application of radioactive iodine in therapy of Graves' disease, J Clin Invest, 21, 624 Hamilton, 1942, Recent clinical developments in the therapeutic application of radio-phosphorus and radio-iodine, J Clin Invest, 21, 624 Seidlin, 1945, Therapeutic effect of radioactive iodine on adenocarcinoma of the thyroid with functioning metastases, Bull NY Acad Med, 21, 440 Blumgart, 1955, Treatment of incapacitated euthyroid cardiac patients with radioactive iodine; summary of results in treatment of 1070 patients with angina pectoris or congestive heart failure, JAMA, 157, 1, 10.1001/jama.1955.02950180003001 Jaffee, 1955, Radioiodine treatment of euthyroid cardiac disease. Four years of experience with two hundred and thirty-one patients, JAMA, 159, 434, 10.1001/jama.1955.02960220024008 Muller, 1950, Weitere Entwicklung der Therapie von peritoneal Carcinosen bei Ovarialcarcinom mit kunstlicher Radioactivitat, Gynaecologia, 129, 298 Bale, 1957, Studies directed towards the use of antibodies as carriers of radioactivity for therapy, vol 5, 286 Belliveau, 1978, Possible therapeutic use of radiolabeled antibodies: a review, 295 Fletcher, 1978, The evolution of the basic concepts underlying the practices of radiotherapy from 1949 to 1977, Radiology, 127, 3, 10.1148/127.1.3 Osgood, 1964, Treatment of chronic leukemias, J Nucl Med, 5, 139 Thomas, 1977, Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer, Radiology, 122, 731, 10.1148/122.3.731 1970 Tabern, 1967, The use of radioisotopes in therapy, Clin Scin, 11, 1 Spencer, 1978, Nuclear medicine and therapy: a reorientation to specificity and beta ray generators Friedman, 1978, Radioastatine: possible uses of a heavy halogen, 139 Hosain, 1978, Selection of radionuclides for therapy, 33 Burrow, 1978, Role of lithium in radioiodine therapy, 113 Hosain, 1978, Selection of radionuclides for therapy, 33 Loevinger, 1968, A formalism for calculation of absorbed dose from radionuclides, Phys Med Biol, 13, 205, 10.1088/0031-9155/13/2/306 Snyder, 1974, A tabulation of dose equivalent per microcurie-day for source and target organs of an adult for various radionuclides Spitznagle, 1978, Use of 3H- and 14C-labeled compounds in the therapy for specific metabolic pathways, 275 Grady, 1978, Adjuvant therapy for colon cancer by internal radiation of the liver, 351 Hazra, 1978, Uses of beta emitters for intracavitary therapy, 307 Chaudhuri, 1978, Role of 32P in polycythemia vera and leukemia, 223 Ariel, 1978, Lymphography and the endolymphatic administration of radioactive isotopes for the treatment of certain cancers, 313 Ariel, 1978, Treatment of metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes, 357 1972 Snyder, 1975, “S”, absorbed dose per cumulated activity for selected radionuclides and organs Thomas, 1977, A comparison of hematopoietic marrow dose from P-32 and P-33 labeled diphosphonate uptake in bone, Med Physics, 4, 345 Kereiakes, 1979, In vivo dosimetry of beta-and gamma-emitting radiopharmaceuticals Mayer, 1978, Sulfur-35 therapy for chondrosarcoma and chordoma, 185 Atkins, 1978, Treatment of hyperthyroidism: use of 131I and 125I, 85 Wald, 1978, Chromosomal alterations after therapeutic use of radionuclides, 45 Lloyd, 1976, A comparison of physical and cytogenic estimates of radiation dose in patients treated with iodine 131 for thyroid carcinoma, Int J Radiat Biol, 30, 473, 10.1080/09553007614551291 Stevenson, 1973, A cytogenic and scanning study of patients receiving intra-articular injection of gold-198 and yttrium-90, Ann Rheum Dis, 32, 112, 10.1136/ard.32.2.112 Stevenson, 1973, Chromosomal damage in human lymphocytes from radioisotope therapy, Ann Rheum Dis [Suppl], 32, 19, 10.1136/ard.32.Suppl.19 1977 1977 1971 1975 1972 1956, The Biological Effects of Atomic Radiation: Report of the Committee on Genetic Effects of Atomic Radiation (BEAR, report). Washington, D. C. Maugh, 1978, Chemical carcinogens: how dangerous are low doses?, Science, 202, 37, 10.1126/science.694517 Maxon, 1977, Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland, Am J Med, 63, 967, 10.1016/0002-9343(77)90552-6 Dobyns, 1974, Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study, J Clin Endocrinol Metab, 38, 976, 10.1210/jcem-38-6-976 1977, 376 Saenger, 1968, Incidence of leukemia following treatment of hyperthyroidism, JAMA, 205, 147, 10.1001/jama.1968.03140380059014 Saenger EL: Personal communication Ultmann, 1963, The occurrence of lymphoma in patients with long-standing hyperthyroidism, Blood, 21, 282, 10.1182/blood.V21.3.282.282 Sarkar, 1976, Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer, J Nucl Med, 17, 460 Pochin, 1967, Prospects from the treatment of thyroid carcinoma with radioiodine, Clin Radiol, 18, 113, 10.1016/S0009-9260(67)80001-1 Bundi, 1977, Chronic myeloid leukemia following radioiodine therapy for carcinoma thyroid, Br J Radiol, 50, 61, 10.1259/0007-1285-50-589-61 Seidlin, 1955, Occurrence of myeloid leukemia in patients with metastatic thyroid carcinoma following prolonged massive radioiodine therapy, Bull NY Acad Med, 31, 410 Kao, 1977, Complications following parametrial radiogold treatment for cervical carcinoma, Obstet Gynecol, 50, 665